News
23h
TipRanks on MSNMerck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by AnalystsAnalysts are intrested in these 5 stocks: ( ($MRK) ), ( ($REGN) ), ( ($CLRB) ), ( ($HUMA) ) and ( ($FL) ). Here is a ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge economic investment for the company, and the small town.
From a spray-on antimicrobial solution for biosecurity to water supplementation products, here's a quick look at the latest news headlines from companies in the livestock industry.
Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...
We recently published a list of 13 Best Cheap Stocks to Invest in for Beginners. In this article, we are going to take a look ...
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
S&P 500 pharma stocks hold firm despite Trump’s drug pricing threat. Is Merck a put-selling opportunity amid headline noise?
We recently published a list of the 20 Best Dividend Growth Stocks with High Yields. In this article, we are going to take a ...
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...
We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...
Merck (MRK) stock gains as its bestselling drug, Keytruda, as part of a combination regimen, succeeds in a Phase 3 trial for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results